Last CNY23.02 CNY
Change Today +0.48 / 2.13%
Volume 16.4M
As of 2:05 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

mayinglong pharmaceutical-a (600993) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/27/14 - CNY23.94
52 Week Low
05/19/14 - CNY15.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MAYINGLONG PHARMACEUTICAL-A (600993)

Related News

No related news articles were found.

mayinglong pharmaceutical-a (600993) Related Businessweek News

No Related Businessweek News Found

mayinglong pharmaceutical-a (600993) Details

Mayinglong Pharmaceutical Group Co., Ltd. is engaged in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, cosmeceutical, and other products, as well as drugstore and merchants varieties. The company provides its products in various dosage forms comprising ointments, suppositories, tablets, pastes and granules, and oral solutions. It also produces and distributes eye cream products under the Mayinglong BaBao brand name; and operates hospitals. The company was founded in 1582 and is based in Wuhan, China.

Founded in 1582

mayinglong pharmaceutical-a (600993) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mayinglong pharmaceutical-a (600993) Key Developments

Mayinglong Pharmaceutical Group Co,.LTD, Board Meeting, Oct 24, 2014

Mayinglong Pharmaceutical Group Co,.LTD, Board Meeting, Oct 24, 2014. Agenda: To consider third quarter report of 2014; to consider the proposal of changing accounting policy; and to consider the proposal of cancelling registration of the company's allied company.

Mayinglong Pharmaceutical Group Stock Co., Ltd. Report Earnings Results for the Nine Months of 2014

Mayinglong Pharmaceutical Group Stock Co. Ltd. reported earnings results for the nine months of 2014. For the period, the company reported basic earnings per share of CNY 0.54 and weighted average return on net assets was 11.97%.

Mayinglong Pharmaceutical Group Co,.LTD to Report Q3, 2014 Results on Oct 25, 2014

Mayinglong Pharmaceutical Group Co,.LTD announced that they will report Q3, 2014 results on Oct 25, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600993:CH CNY23.02 CNY +0.48

600993 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600993.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600993 Industry Range
Price/Earnings 36.1x
Price/Sales 4.5x
Price/Book 4.7x
Price/Cash Flow 35.6x
TEV/Sales 3.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAYINGLONG PHARMACEUTICAL-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at